Cybergenetics offers TrueAllele, a fully automated probabilistic genotyping technology that interprets complex DNA mixtures from forensic evidence, providing reliable identification information for criminal cases. This technology addresses the challenge of inconclusive DNA data, enabling accurate matches and supporting legal proceedings in tens of thousands of cases.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional DNA analysis methods often struggle with complex DNA mixtures, leading to inconclusive results and hindering criminal investigations, retail theft prevention, and advanced medical diagnostics. These inconclusive results can delay justice, allow retail crime to persist, and limit the potential of personalized medicine.
Solution
Cybergenetics offers TrueAllele, a probabilistic genotyping technology that uses artificial intelligence and applied mathematics to resolve complex DNA data. TrueAllele transforms previously uninterpretable forensic DNA evidence into useful identification information, enabling accurate matches in criminal cases, identifying perpetrators of organized retail crime, and improving the accuracy of NextGen sequencing data analysis for better disease diagnosis and care. The ORCA (Organized Retail Crime Annihilator) platform, powered by TrueAllele, delivers crime scene DNA identification information to loss prevention professionals. Cybergenetics also provides services including DNA problem solving and expert testimony.
Target Audience
The primary target audiences include law enforcement agencies, forensic scientists, retail loss prevention professionals, and medical professionals involved in cancer testing and diagnostics.
Features
- Fully automated probabilistic genotyping for complex DNA mixtures
- AI-powered analysis of NextGen Sequencing data for improved disease diagnosis
- ORCA platform for identifying perpetrators of organized retail crime
- Ability to reanalyze crime lab data to solve cold cases
- Identification of shared DNA to connect crime scenes
- Assistance in exonerating the wrongfully convicted
- Separation of mixed cells using software for more accurate analysis